Skip to content

Study · Not a test of the peptide alone · 2012

1 result

D-Ser-containing humanin shows promotion of fibril formation.

Hayashi K, Sasabe J, Chiba T, Aiso S, Utsunomiya-Tate N

Amino acids7 Jul 2011Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Humanin.

  1. 01LabNot a test of Humanin aloneIn vitro (cell-free)Mechanism

    In a thioflavin-T assay, a humanin derivative with two D-Ser residues formed fibrils more readily than wild-type humanin or derivatives with single D-Ser residues.

    In plain wordsIn lab tests, a humanin derivative with two D-Ser residues formed fibrils more readily than normal humanin or single D-Ser versions.

    Peptide
    Humanin
    Outcome
    IncreaseFibril formation of humanin with two D-Ser residues
    Study

    n: not reported in source

    Thioflavin-T assay of synthetic peptides
    Comparator
    Wild-type HN and HNs with single D-Ser residues
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    we found that an HN derivative that contained two isomerized D-Ser residues had a greater tendency to form fibrils than did wild-type HN or HNs containing single D-Ser residues.

    In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Humanin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.